Qiu-hua Gu

No.154 Anshan Road
Xiaobailou, 300052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Significance of glomerular IgG3 deposition in patients with primary membranous nephropathy.

Significance of glomerular IgG3 deposition in patients with primary membranous nephropathy.

Journal: Autoimmunity
Published: January 27, 2026

Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China.

Long-term real-world outcomes of rituximab in primary membranous nephropathy: a 154-patient cohort study from China.

Journal: Renal failure
Published: January 25, 2026

Serum matrix metalloproteinase-9 levels and enzymatic activity in patients with anti-glomerular basement membrane disease.

Serum matrix metalloproteinase-9 levels and enzymatic activity in patients with anti-glomerular basement membrane disease.

Journal: Frontiers in medicine
Published: July 18, 2025

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study.

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study.

Journal: Frontiers in immunology
Published: June 19, 2025

Significance of urinary and serum neutrophil gelatinase-associated Lipocalin in Antineutrophil cytoplasmic antibody-associated Vasculitis with glomerulonephritis.

Significance of urinary and serum neutrophil gelatinase-associated Lipocalin in Antineutrophil cytoplasmic antibody-associated Vasculitis with glomerulonephritis.

Journal: International immunopharmacology
Published: May 10, 2025

Serum ferritin is a superior biomarker for evaluating disease activity and kidney injury compared with C-reactive protein in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Serum ferritin is a superior biomarker for evaluating disease activity and kidney injury compared with C-reactive protein in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Journal: Clinical rheumatology
Published: December 25, 2024

Efficacy and safety of belimumab in lupus nephritis patients with nephrotic syndrome: a single-centre observational retrospective study.

Efficacy and safety of belimumab in lupus nephritis patients with nephrotic syndrome: a single-centre observational retrospective study.

Journal: Clinical kidney journal
Published: September 13, 2024

Profiling dendritic cells subsets in renal tissue of patients with crescentic glomerulonephritis.

Profiling dendritic cells subsets in renal tissue of patients with crescentic glomerulonephritis.

Journal: International urology and nephrology
Published: January 16, 2024

The protease inhibitor E64d might attenuate the development of experimental anti-glomerular basement membrane disease through regulating the activation of Th1 cells.

The protease inhibitor E64d might attenuate the development of experimental anti-glomerular basement membrane disease through regulating the activation of Th1 cells.

Journal: International immunopharmacology
Published: December 19, 2023

Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease.

Short-chain fatty acids ameliorate experimental anti-glomerular basement membrane disease.

Journal: Clinical immunology (Orlando, Fla.)
Published: September 09, 2023

Significance of thyroid dysfunction in the patients with primary membranous nephropathy.

Significance of thyroid dysfunction in the patients with primary membranous nephropathy.

Journal: BMC nephrology
Published: August 09, 2022

Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy.

Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy.

Journal: Kidney international
Published: December 12, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026